| Publication Date | Title | Author(s) |
| Sep-1995 | C reactive protein and prealbumin as markers of disease activity in shigellosis | Khan, W.A.; Salam, M.A.; Bennish, M.L. |
| Sep-1985 | A double blind trial of loperamide for thetreatment of watery diarrhoea in expatriates in Banglades[abstract] | Speelman, P.; Van loon, F.P.; Bennish, M.L. |
| Apr-1989 | Double blind trial of loperamide for treating acute watery diarrhoea in expatriates in Bangladesh | van Loon, F.P.L.; Bennish, M.L.; Speelman, P.; Butler, C. |
| Mar-1998 | Efficacy and safety of ciprofloxacin suspension in the treatment of childhood shigellosis(abstract) | Salam, M.A.; Dhar, U.; Khan, Wasif A.; Bennish, M.L. |
| Jun-1997 | Features of shigella associated hemolytic uremic stndrome (HUS) in children | Azim, Tasnim; Ronam, A.; Khan, W.A.; Salam, M.A,; Albert, J.; Bennish, M.L. |
| Sep-1985 | The importance of bacterimia as a cpmplication of diarrheal illness in Bangladesh[abstract] | Struenens, M.J.; Bennish, M.L.; Patte, D.; Mondal, G.; Rahman, M.; Coignau, H. |
| 1986 | Interventions to reduce deaths from dysentery in rural Bangladesh[abstract] | Wierzba, T.; Bennish, M.L.; Paramanik, N. |
| 1986 | Loperamide for the treatment of watery diarrhoea: a double-blind trial in expatriates in Bangladesh. | van Loon, F.P.L.; Bennish, M.L.; Speelman, P.; Butler, T.C. |
| 1999 | Mortality, morbidity and microbiology of endemic cholera in Bangladesh [abstract] | Ryan, E.T.; Dhar, U.; Khan, W.A.; Salam, M.A.; Faruque, A.S.G.; Fuchs, G.J.; Calderwood, S.B.; Bennish, M.L. |
| 2002 | Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children | Bennish, M.L.; Khan, W.A.; Kindra, G.; Mason, E.M.; Nathoo, K.J.; Ries, A.A.; Rollins, N.C.; Schall, R.; Sprenger, K.; Wellington, M. |
| 1998 | Neurologic manifestations of childhood shigellosis | Khan, Wasif A.; Dhar, Ujjwal; Salam, Mohammed A.; Bennish, M.L. |
| 1989 | Randomized, blinded, trial of ciprofloxacin (CIP) for the treatment of shigellosis[abstract] | Bennish, M.L.; Salam, M.A.; Haider, R.; Barza, M. |
| Oct-1994 | Randomized, double-blinded comparision of single dose clprofloxacin with single dose doxyeycllne in the treatment of vibrio cholerae 0139 (Bengal) infection | Khan, W.A.; Seas, C.; Khan, E.H.; Salam, M.A.; Bennish, M.L. |
| Jun-1999 | Sequential stool shiga toxin excretion folling antimicrobial therapy of shigella dysenteriae type-1 infection[abstract] | Khan, W.A.; Begum, M.; Ryan, E.T.; Salam, M.A.; Acheson, D.W.K.; Bennish, M.L. |
| 1986 | Shigella toxin production in human shegelosis[abstract] | Bennish, M.L.; Denohue-Rolfe, A.; Azad, A.K.; Hardy, R.; Keusch, G.T. |
